Professional Documents
Culture Documents
Liver Review: Dr. Ahmed Kandil, MD, Phd. Consultant Surgeon Head of Surgery Department Shifa Hosp. - Gaza
Liver Review: Dr. Ahmed Kandil, MD, Phd. Consultant Surgeon Head of Surgery Department Shifa Hosp. - Gaza
1
Anatomy
Anatomical lobes: Liver seems to divide
into big Rt & Small Lt lobes by falciform
ligament.
Surgical lobes: Liver divided into 2 ± lobes
by the portal fissure or Cantlies line. It is a
plane passing from the left side of the
gallbladder fossa to the left side of the
IVC.
2
Anatomy
3
Anatomy
Segments:
Eight segments, based on arterial and portal
venous inflow.
Segment 1 is the caudate lobe of the liver.
Segments 2-4 are segments of the left lobe
resected during left hepatic lobectomy.
Segments 5-8 are segments of the right lobe
resected during right hepatic lobectomy.
This after French surgeon Henry Bismuth.
4
Segments
5
Anatomy
Portal vein is a valveless vein formed by
SMV and splenic vein behind head of
pancreas.
Passes posteriorly to the bile duct and
hepatic artery in the hepatoduodenal
ligament.
75% of liver’s blood supply.
6
Anatomy
Portal vein drains blood from the small and
large intestines, stomach, spleen, pancreas,and
gallbladder.
The portal trunk divides in to 2 lobar veins, the
right drains the cystic vein, the left receives
umbilical and paraumbilical veins that enlarge to
form the caput medusae. The coronary vein
drains the distal esophagus, which also enlarge
in PHTN.
7
Anatomy
Common hepatic artery arises from the celiac
artery and becomes the proper hepatic artery
after the GD branches.
Passes medial to the bile duct and anterior to
portal vein.
Bifurcates into right and left hepatics in liver
parenchyma.
Can come off SMA (right) or Left gastric (left).
Pringle maneuver.
8
9
Liver Trauma
Predisposing factors:
1- Hepatomegally
2- Diseased liver
Causes:
1- Closed trauma
2- Open (penetrating) injury
3- Iatrogenic injury
4- Spontaneous rupture
10
Liver Trauma
Types of injury:
Subcapsular hematoma or intrahepatic
hematoma.
Contusion
Laceration
Hepatic vascular disruption
Bile duct injury
Most of injuries have stopped bleeding at time of
exploration.
Decreased transfusion req. with conservative
11
Liver Trauma – Scaling system
12
Liver Trauma
Clinical Assessment:
Unstable patients (systolic BP>90mmHg)
Should go immediately to OR.
Stable patients but with obvious signs of
internal bleeding, preparation and sent
rapidly to OR.
Stable patients with equivocal signs we
have time to investigate and observe.
13
Liver Trauma
Investigations:
Routine investigations
U S abdomen
DPL
C T abdomen
Laparoscopy
14
Liver Trauma
Management:
Immediate operation
Rapid operation after some preperations
non operative management
Delayed operation
15
Liver Trauma
Different surgical procedures:
Cautary , local haemostatic agents
Suturing
Omental packing
perihepatic packing
Wrapping of the lacerated liver
Others
16
Infections of Liver
Pyogenic liver abscesses (80% of all liver
abscesses).
Routes of infection are portal, ascending biliary
tree, bacteremia via hepatic artery, direct
extension (appendicitis), primary infection post
trauma.
Intra-abdominal infection most common
identifiable source (biliary, colonic).
TTT: Antibiotics plus drainage, look for source.
17
Infections of Liver
Amebic Liver abscess, entamoeba histolytica.
Via portal venous system after intestinal
infection after a trophozoite is ingested.
Contains necrotic tissue and blood, anchovy
paste.
Right lobe (80%), solitary (80%).
CT scan (? One?) Antibody test specific.
Non surgical, Flagyl. Surgery if rupture or
secondary infection.
18
Infections of Liver
Hydatid Liver Cysts are rare liver cysts, right
lobe, echinococcal, dogs that eat sheep (carrier).
Vague abdominal pain, jaundice.
Ct characteristic (calcified wall), ELISA test for
antibody >90%, eosinophilia (10-30%).
Surgical drainage, hypertonic saline, removal of
cyst wall, don’t spill it! anaphylaxis.
Mebendazole
19
Benign Tumors
20
Liver cysts
Simple Cysts: If sympt, rupture, infection,
bleed, or suspicious. Surgical treatment;
Unroof, oversew.
Polycystic liver disease: Associated with
renal failure. Women 30-80, 50% PC
kidneys as well
21
Malignant Tumors
Hepatocellular carcinoma (HCC) most
common, men, 40-70. Risks: cirrhosis,
Hep B, Hep C, carcinogens,
hemachromatosis, tyrosinemia, glycogen
storage, Wilson’s, adenoma,
schistosomiasis, alpha-1 antitrypsin
deficiency, blood group B.
22
Malignant Tumors
Dx: AFP (elevated 40-70%), US, CT, MRI
TX: 5-y survival 31% for resectable
tumors. With no treatment, 1-4
months,11% operative mortality, cirrhosis
is the limiting factor, recurrence 50%, so
transplant an option.
Chemo is no benefit, transarterial
embolization, ethanol injection may help.
23
Malignant Tumors
Liver metastases are most common
tumors of liver! Much more frequent than
primary tumors.
Colon, lung, breast, melanoma, carcinoid,
renal cell.
DX: CEA a reliable indicator for recurrence
of colon cancer previously treated. CT
scan, IOUS.
24
Malignant Tumors
TX: Liver resection other than for colon cancer
show no reliable benefit.
5-y survival post resection 30-35%(colorectal).
Untreated <5%.
5% operative mortality.
Size, number, location, extent of primary tumor,
resectable lesions are a small minority of
patients. If mets to other areas of body,
contraindicated.
25
Malignant Tumors
Hepatoblastomas are primary malignant
tumors of liver seen in boys younger than
2 years old.
Cholangiocarcinomas are primary
malignant tumors of biliary ductal
epithelium, can present as intrahepatic or
extrahepatic lesions.
26
Portal Hypertension
27
Background
Portal pressure gradient 12 mmHg or
more
Often associated with varices and ascites.
Many conditions are associated with it, the
most common being cirrhosis of the liver.
28
Causes of Portal HTN
29
Four Major Consequences
Ascites
Portosystemic venous shunts and varices.
Congestive splenomegaly
Hepatic encephalopathy
30
Mortality/Morbidity
Variceal hemorrhage most common
complication
90% with cirrhosis develop varices.
30% of these bleed.
The first episode is estimated to carry a
mortality of 30-50%.
31
32
History
Directed towards determining the cause,
the presence of complications of portal
hypertension.
Jaundice, transfusions, pruritis, hereditary
liver disease,…
Hematemesis, melena, mental status,
abdominal girth, pain, fever,
hematochezia?
33
Physical Examination
Signs of portosystemic collateral formation:
Dilated veins in abdominal wall
Caput medusa
Rectal hemorrhoids
Ascites
Umbilical hernia
34
Signs of Liver Disease
Ascites
Jaundice
Palmar erythema
Testicular atrophy, gynecomastia
Muscle wasting, Dupuytren contracture
Splenomegaly
35
Dilated veins
36
Ascites
37
Palmer Erythema
38
Gynecomastia
39
Lab Studies
LFTs
PT/PTT
Albumin
Hepatitis serology
Platelets
ANA, Antimitochondrial antibodies
Alpha 1-antitrypsin deficiency
40
Imaging Studies
Duplex is safe, noninvasive. Demonstrates
portal flow, portal vein thrombosis, splenic
vein thrombosis
Nodular liver surface, splenomegaly,
presence of collateral circulation.
Limitations include meals, meds,
sympathetic nervous system affect flow.
41
Imaging Studies
CT scan when US inconclusive
Look for collaterals from portal system
Dilatation of the vena cava suggests portal
hypertension.
Limitations include not being able to use
IV contrast in allergic patients or with renal
failure.
42
Incidental Finding on Barium Swallow
43
Procedures
Hemodynamic measurement of pressure,
usually not performed due to invasive
nature. Measures hepatic venous pressure
gradient (HVPG). Similar to Swan Ganz,
where balloon is inflated measuring
wedged hepatic venous pressure, minus
the unoccluded pressure is the HVPG.
44
Procedures
Endoscopy is performed to screen for
varices.
Gastroesophageal varices confirms
diagnosis of portal hypertension, absence
does not rule it out.
Many times an incidental finding when
scoped for something else.
45
Varices on EGD
46
Varix Banding
47
Medical Care
Treatment is directed at cause:
Emergent treatment
Primary prophylaxis
Elective treatment
48
Emergent Treatment
Bleeding from varices ceases spontaneously in
40%. Rebleed in 40% within 6 weeks.
Following resuscitation, treatment includes
control of bleeding, prevention of recurrence,
blood replacement, avoid over expansion of
volume status.
Diagnose source of bleed, specific treatment of
bleeding lesion.
49
Emergent Treatment
All patients with cirrhosis and upper GI
bleed are at risk for severe bacterial
infections, which are associated with early
rebleed.
Use of antibiotics shown to increase
survival, decrease rate of infection.
Thus prophylactic use of antibiotics in
acute bleeding is recommended.
50
Pharmacologic Therapy
Somatostatin-decreases portal flow, splanchnic
vasoconstriction.
Octreotide- 50mcg/h shown to reduce
complications of bleeding after sclerotherapy.
Vasopressin- reduces blood flow to all
splanchnic organs, decreases portal pressure,
venous blood flow. Use nitroglycerin with it! It’s
the most potent splanchnic vasoconstrictor.
51
Endoscopic Therapy(EST, EVL)
Hemostasis in 80%, declines to 70% at day 5
due to very early rebleeding.
No more than 2 sessions before deciding on
TIPS or surgery.
Complications include fever, stricture,
perforation, mediastinitis, ulceration, pleural
effusion.
EVL and EST comparable in control of bleeding
EST associated with more complications.
52
Sengstaken Tube
53
Minnesota Tube
Balloon tamponade only in massive
bleeding as a temporizing measure.
Complications
Has 4 lumens, 1 for gastric aspiration, 2 to
inflate the balloons, 1 above the
esophageal balloon to prevent aspiration.
Usually only need to inflate gastric balloon.
54
Prophylaxis
Beta-blockers (propanolol, nadolol) are
non cardioselective, reduce portal and
collateral blood flow. Also reduces cardiac
output, splanchnic vasoconstriction.
First bleeding rates significantly reduced,
mortality rates lower as well
55
Prophylaxis
No role for sclerotherapy in primary
prophylaxis.
EVL is more effective than no treatment to
prevent first bleed. Similar efficacy to beta-
blockers, with more adverse effects.
Not recommended for primary prophylaxis
except perhaps in patients with very large
varices.
56
Elective Treatment
This is for prevention of rebleeding (2 year
recurrence rate of 80%).
Propanolol and nadolol, reduce rebleed,
increase survival.
Beta blockers vs sclerotherapy have comparable
rates of prevention
EVL is considered treatment of choice in
prevention of rebleeding, may combine with
drugs.
57
Surgical Treatment (Shunts)
Total Portosystemic shunts include any
shunt larger than 10mm between portal
vein and IVC. Includes Eck (end to side)
and side to side portocaval shunts.
Eck fistula controls bleeding, but ascites
unrelieved.
Side to side controls bleeding and ascites,
but encephalopathy a problem (40-50%).
58
Surgical Shunts
Partial portal systemic shunts reduce the
size to 8mm in diameter.
Use an interposition graft between portal
vein and IVC.
90% control of bleeding, decreased
incidence of encephalopathy and liver
failure.
59
Surgical Shunts
Selective shunts aim to decompress varices
whilst maintaining portal hypertension to
maintain portal flow to liver.
Warren distal splenorenal shunt, the most
commonly used for patients with refractory
bleeding and good liver function. Decompresses
GE varices thru short gastrics, spleen, splenic
vein to left renal vein. Lower incidence of
encephalopathy (15%), preserves some liver
function. It does produce ascites.
60
Splenorenal Shunt
61
Devascularization Procedures
Include splenectomy, gastroesophageal
devascularization, esophageal transection.
Incidence of encephalopathy is low, because of
maintenance of portal flow.
Used in patients who are not candidates for
decompression in whom 1st line therapy has
failed. This includes pts with splenic or portal
vein thrombosis in addition to cirrhosis
62
Denver and Leveen Shunts
Subcutaneous shunts that drain ascitic
fluid from the abdomen into the central
venous system.
Come with pressure valves.
DIC is a known complication of
peritoneovenous shunting of ascitic fluid.
63
64
Devascularizaton
Splenectomy- the spleen is a major inflow
path to GE varices. Splenectomy gives
better access to fundus and distal
esophagus to complete the
devascularization.
Complicated by portal vein thrombosis,
and ascites.
65
Devascularization
Sugiura procedure- devascularizes
whole greater curve from pylorus to
esophagus, upper two thirds of lesser
curve. The esophagus is devascularized a
minimum of 7 cm.
66
Liver Transplant
The ultimate shunt, as it relieves portal
hypertension, prevents bleeding, manages
ascites and encephalopathy by restoring
liver function.
Child class A: shunt surgery
Child class B: shunt or TIPS
Child class C: TIPS or liver transplant
67
68
Child’s Classification
A: 2% mortality
B: 10% mortality
C: 50% mortality
69
Tips= Transjugular Intrahepatic
Portasystemic Shunt
For continued bleeding despite medical and
endoscopic treatment in patients with Child C
disease and selected Child B disease.
It is only useful in portal hypertension of hepatic
origin.
Internal jugular to hepatic vein thru hepatic
parenchyma to portal vein. Tract dilated and
stented.
70
TIPS
71
Accepted Indications
Active bleeding despite endoscopic or
pharmacologic treatment
Recurrent variceal bleeding despite
adequate endoscopic treatment.
Potential indications include bleeding
gastric fundic varices, refractory ascites.
A bridge to transplantation.
72
Complications of TIPS
Hematoma, cardiac arrythmias,
bacteremia
Perihepatic hematoma, rupture of liver
capsule
Extrahepatic punture of portal vein
Arterioportal fistula, portobiliary fistula
Encephalopathy (30%)
Liver failure
73
Overview of Treatments
74
Splenic Vein Thrombosis
Can lead to isolated gastric varices without
elevation of pressure in portal system
These gastric varices can bleed
Most often caused by pancreatitis
Treatment is splenectomy.
75
Liver Review
76